BSE filing, NSE: SANDUPHQ. Summary written from the filing by ALFA Finder's alert engine.
Sandu Pharmaceuticals Ltd: key numbers
- Share price
- ₹35.95
- Market cap
- ₹34.73 Cr
- Revenue (annual)
- ₹69.93 Cr
- Net profit (annual)
- ₹1.77 Cr
- P/E (TTM)
- 14.3×Sector 45.9×
- Promoter holding
- 37.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandu Pharmaceuticals Ltd
All →Sandu Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals intimated that Non-Executive Independent Director Dr Neeti Madan Kapre has changed her name to Dr Neeti Gupta after marriage. The DIN, designation and directorship remain unchanged.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals Limited has issued a reminder to physical shareholders regarding the mandatory submission of PAN and KYC details. This compliance follow-up aims to facilitate electronic dividend payments.
Sandu Pharmaceuticals Management Change
Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals has appointed M/s. Dave & Dave as Statutory Auditors for a five-year term, following the tenure expiry of the previous auditors.
Sandu Pharmaceuticals Annual General Meeting
Sandu Pharmaceuticals Limited held its 41st Annual General Meeting on September 11, 2026, via video conferencing to transact ordinary and special business items.
Other financial results announcements
All →Finolex Industries Q2 FY27 Results: Net Profit ₹115 Cr, Down 7.0% YoY
Finolex Industries Ltd reported revenue from operations of ₹1,094 Cr (+27.4% YoY) and net profit of ₹115 Cr (-7.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹115 Cr · -7.0% YoY
Fabtech Cleanrooms H1 FY27 Results: Net Profit ₹5.2 Cr, Up 57.6% YoY
Fabtech Cleanrooms Ltd reported revenue from operations of ₹133.2 Cr (+74.8% YoY) and net profit of ₹5.2 Cr (+57.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.2 Cr · +57.6% YoY
IRM Energy Q2 FY27 Results: Net Profit ₹25.4 Cr, Up 101.6% YoY
IRM Energy Ltd reported revenue from operations of ₹363.6 Cr (+29.0% YoY) and net profit of ₹25.4 Cr (+101.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹25.4 Cr · +101.6% YoY
Chemkart India H1 FY27 Results: Net Profit ₹22.6 Cr, Up 121.6% YoY
Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹22.6 Cr · +121.6% YoY
Share India Securities Q2 FY27 Results: Net Profit ₹102.5 Cr, Up 10.0% YoY
Share India Securities Ltd reported revenue from operations of ₹379.5 Cr (+11.3% YoY) and net profit of ₹102.5 Cr (+10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹102.5 Cr · +10.0% YoY
Pasari Spinning Mills Q2 FY27 Results: Net Profit ₹0 Cr
Pasari Spinning Mills Ltd reported net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr